Greenwood Capital Associates »

Krystal Biotech shares owned by Greenwood Capital Associates

Quarter-by-quarter ownership of Krystal Biotech (KRYS) shares owned by Greenwood Capital Associates from 13F filings

Historical chart of Greenwood Capital Associates investment in Krystal Biotech

Tip: Access up to 7 years of quarterly data

All positions including Krystal Biotech held by Greenwood Capital Associates consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Krystal Biotech by Greenwood Capital Associates

Quarter filed Position value Share count Share price at filing
2026-06-30 $556k 1.5k 371.67
2026-03-31 $215k 834 258.32

More positions owned by Greenwood Capital Associates

Apple (AAPL)
Ishares Tr Core S&p500 Etf (IVV)
Alphabet Cap Stk Cl A (GOOGL)
J P Morgan Exchange Traded F Beta Euro Et Ne (BBEU)
Microsoft Corporation (MSFT)
Amazon (AMZN)
Ishares Msci Emrg Chn (EMXC)
Dimensional Etf Trust World Ex Us Core (DFAX)
International Business Machines (IBM)
Ishares Tr Core Msci Pac (IPAC)
Berkshire Hathaway Inc Del Cl B New (BRK.B)
Ishares Tr Intrm Gov Cr Etf (GVI)
Ishares Tr Core Us Aggbd Et (AGG)
Eli Lilly & Co. (LLY)
Palo Alto Networks (PANW)

View all positions for Greenwood Capital Associates

Top funds holding Krystal Biotech

FMR
BlackRock
venBio Select Advisor
Vanguard Portfolio Management
State Street Corporation
Vanguard Capital Management
Soleus Capital Management
Capital World Investors
Vestor Capital Corp
Geode Capital Management
Hood River Capital Management
Redmile Group
William Blair Investment Management
T. Rowe Price Associates
Frazier Life Sciences Management

View all funds holding Krystal Biotech